CUHK_CCT00063
2005-09-12
Retrospective
n/a
N/A
Roche
n/a
Benny Fok
Department of Medicine and Therapeutics
26323377
bfok@cuhk.edu.hk
The Chinese University of Hong Kong
Brian Tomlinson
Department of Medicine and Therapeutics
26323139
btomlinson@cuhk.edu.hk
The Chinese University of Hong Kong
A placebo controlled, randomized study to examine the impact of 24-week orlistat treatment on postprandial triglyceridaemia, steatohepatitis and cardiovascular risk factors in overweight Chinese patients
A placebo controlled, randomized study to examine the impact of 24-week orlistat treatment on postprandial triglyceridaemia, steatohepatitis and cardiovascular risk factors in overweight Chinese patients
n/a
Hong Kong
Yes
2003-11-04
Obesity
Drug
Orlistat
24 weeks
Placebo
Chinese patients with obesity and dyslipidaemia
Patients on orlistat within one month prior to study
18
78
Both Male and Female
Interventional
Randomized
Placebo
Double-blind
Parallel
2004-01-01
40
Complete
Postprandial triglyceridaemia, visceral and hepatic fat deposition
Body weight, cardiovascular risk profiles
2009-11-27
ChiCTR-TRC-09000655
2010-05-04
Yes
n/a
|
|
|
|
|
---|---|---|---|---|
No documents yet. |